Contact Information
email: hsinminwang@ufl.edu
Education
- Pharm.D., National Cheng Kung University, Taiwan, 2014-2019
- Master of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Taiwan, 2019-2020
Entry Date into the POP Ph.D. program: Fall, 2021
Research Interests
I’m interested in antipsychotics, antidepressants, cholinesterase inhibitors, and other drugs used for neuropsychiatric diseases in geriatric populations. My outcomes of interest include comparative effectiveness, safety, and drug-drug interaction.
Professional Experience
- research assistant, 2020-2021
- clinical pharmacist at wards of nephrology and general internal medicine, 2019-2020
Scholarships/Awards
- Full Scholarship for the 2021 ICPE Virtual Meeting, Jun 2021
- Honorary Membership of the Phi Tau Phi Scholastic Honor Society of the Republic of China, Jun 2020
- Outstanding Master’s Thesis Award at National Cheng Kung University, Jun 2020
- Taiwan Pharmacist Association Award, Jun 2019
- Presidential Award at National Cheng Kung University, Jun 2015, Jun 2016, Jun 2018
Publications
- Use of antipsychotic drugs and cholinesterase inhibitors and risk of falls and fractures: self-controlled case series
(DOI: 10.1136/bmj.n1925) Accepted by the BMJ on Jul 27 2021 - Global epidemiology of hip fractures: a study protocol using a common analytical platform among multiple countries (https://bmjopen.bmj.com/content/11/7/e047258.abstract)